Free Trial

Roundhill GLP-1 & Weight Loss ETF Rating

Roundhill GLP-1 & Weight Loss ETF logo
$27.51 0.00 (0.00%)
As of 02:40 PM Eastern

Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

OZEM Aggregate Rating

Moderate Buy
2.62

Holdings in OZEM have an aggregate rating of Moderate Buy based on 231 analyst ratings issued in the past year covering 14 companies (71.0% of the portfolio).

OZEM Aggregate Price Target

$27.51
High Prediction$27.51
Average Prediction$27.51
Low Prediction$27.51

Holdings in OZEM have an aggregate price target of $27.51 and a range of $27.51 to $27.51 covering 14 companies (71.0% of the portfolio).

OZEM Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
Moderate Buy
9 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 14 OZEM Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
16.92%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$53.24
-0.3%
4.3054 of 5 stars
2.50$76.00 42.8%20Trending News
15.73%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$820.97
+1.1%
4.9033 of 5 stars
2.68$938.61 14.3%25Trending News
Upcoming Earnings
Analyst Forecast
5.78%
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$33.92
+8.0%
3.9735 of 5 stars
2.73$86.50 155.0%15News Coverage
Earnings Report
Analyst Downgrade
Gap Up
4.50%
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
$26.56
-0.4%
3.2437 of 5 stars
2.70$68.67 158.5%10
3.80%
Metsera Inc. stock logo
MTSR
Metsera
$52.63
-0.3%
N/A2.38$55.75 5.9%8
3.64%
Pfizer Inc. stock logo
PFE
Pfizer
$24.68
-0.2%
4.9584 of 5 stars
2.39$28.13 14.0%18Positive News
3.62%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$83.40
0.0%
3.2343 of 5 stars
2.60$86.00 3.1%5Short Interest ↓
Analyst Revision
3.53%
Amgen Inc. stock logo
AMGN
Amgen
$292.89
-1.0%
4.3892 of 5 stars
2.28$300.94 2.7%18Positive News
2.93%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$7.50
-7.9%
4.0103 of 5 stars
2.56$13.92 85.6%9Trending News
Analyst Forecast
2.72%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$575.69
-1.5%
4.8652 of 5 stars
2.79$817.88 42.1%29Positive News
Upcoming Earnings
Analyst Forecast
2.07%
Biohaven Ltd. stock logo
BHVN
Biohaven
$16.33
-0.9%
3.4074 of 5 stars
3.00$48.85 199.2%16
2.01%
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$28.66
+0.5%
4.4218 of 5 stars
3.07$48.50 69.2%14Analyst Forecast
Gap Down
1.99%
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
$109.12
0.0%
3.0217 of 5 stars
2.94$107.21 -1.7%17Insider Trade
1.79%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$120.74
-0.6%
4.909 of 5 stars
2.81$122.61 1.5%27Trending News
Upcoming Earnings
Analyst Forecast

This page (NASDAQ:OZEM) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners